Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00543
|
|||||
| Drug Name |
Troleandomycin
|
|||||
| Synonyms |
Aovine; Cyclamycin; Evramicina; Matromicina; Matromycin T; Oleandocetin; Oleandocetine; Oleandomycin triacetate; Oleandomycin triacetyl ester; Oleandomycin, triacetate (ester); T.A.O; T.A.O.; TAO; Tao (TN); Tao (VAN); Tekmisin (TN); Treis-Micina; Treolmicina; Triacetyl ester of oleandomycin; Triacetyloleandomycin; Triacetyloleandomycin (JAN); Triacetyloleandomycinum; Tribiocillina; Triocetin; Triocetin (TN); Triolan; Troleandomicina; Troleandomicina [INN-Spanish]; Troleandomycin (TAO); Troleandomycin (USP/INN); Troleandomycin [USAN:INN]; Troleandomycine; Troleandomycine [INN-French]; Troleandomycinum; Troleandomycinum [INN-Latin]; Viamicina; WY 651; Wytrion
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C41H67NO15
|
|||||
| Canonical SMILES |
CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C
|
|||||
| InChI |
InChI=1S/C41H67NO15/c1-19-17-41(18-49-41)38(46)23(5)34(53-27(9)43)21(3)25(7)52-39(47)24(6)35(56-32-16-31(48-14)36(26(8)51-32)54-28(10)44)22(4)33(19)57-40-37(55-29(11)45)30(42(12)13)15-20(2)50-40/h19-26,30-37,40H,15-18H2,1-14H3/t19-,20+,21-,22+,23+,24+,25+,26-,30-,31-,32-,33-,34+,35-,36-,37+,40-,41+/m0/s1
|
|||||
| InChIKey |
LQCLVBQBTUVCEQ-GSELTXNRSA-N
|
|||||
| CAS Number |
CAS 2751-09-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 814 | Topological Polar Surface Area | 184 | ||
| Heavy Atom Count | 57 | Rotatable Bond Count | 12 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 16 | |||
| XLogP |
4.3
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.